EcoR1 Capital »

Bridgebio Oncology Therapeut shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 2.8M 11.58

More positions owned by EcoR1 Capital

Zymeworks Del (ZYME)
Anaptysbio Inc Common (ANAB)
Uniqure Nv SHS (QURE)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Crinetics Pharmaceuticals In (CRNX)
Crispr Therapeutics Namen Akt (CRSP)
Tango Therapeutics (TNGX)
Oric Pharmaceuticals (ORIC)
Apellis Pharmaceuticals (APLS)
Xencor (XNCR)
Galapagos Nv Spon Adr (GLPG)
Immunome (IMNM)
Eton Pharmaceuticals (ETON)
Mbx Biosciences (MBX)
Madrigal Pharmaceuticals (MDGL)

View all positions for EcoR1 Capital

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut